earnings
confidence high
sentiment positive
materiality 0.75
CONMED Q2 adj EPS $1.15 beats; raises FY2025 revenue and adj EPS guidance
CONMED Corp
2025-Q2 EPS reported
$0.88
revenue$663,600,000
- Q2 sales $342.3M (+3.1% YoY); GAAP EPS $0.69 (down from $0.96), adj EPS $1.15 (up from $0.98).
- Single-use products +6.6% to $297.8M; capital products -15.5% to $44.5M.
- FY revenue guidance raised to $1.356B-1.378B; adj EPS raised to $4.40-4.55 (prior $4.31-4.46).
- Company estimates ~$0.09 EPS headwind from tariffs in H2 2025.
- Operational optimization consulting fees $7.6M in Q2; exec transition costs $12.2M YTD.
item 2.02item 9.01